The current institutional shareholding score of Fulcrum Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 104.53%, representing a quarter-over-quarter decrease of 26.94%. The largest institutional shareholder is Steven Cohen, holding a total of 2.35M shares, representing 3.12% of shares outstanding, with 0.20% increase in holdings.